ENVB — Enveric Biosciences Share News
0.000.00%
Last trade - 00:00Brief: Enveric Biosciences Inc - Receives U.S. Patent For Evm301 Series Of Drug Candidates On March 17
Brief: Enveric Biosciences Announces Registration Of Five Trademarks
Brief: Enveric Biosciences Announces Withdrawal Of Pgr Petition Filed By Gilgamesh Pharmaceuticals Against Its Patent
Brief: Enveric Biosciences Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
NASDAQ RESUMED AT 02:20 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:10 PM
NASDAQ RESUMED AT 02:05 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:00 PM
NASDAQ RESUMED AT 01:58 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:43 PM
Enveric Biosciences Q3 net loss widens
Brief: Enveric Biosciences Announces Reverse Stock Split
Brief: Enveric Biosciences Says Selling Stockholders Are Offering On A Resale Basis An Aggregate Of 4.8 Million Shares Of Common Stock - SEC Filing
Brief: Enveric Biosciences Receives FDA Response And Streamlines Plans For EB-003 IND Submission
Brief: Enveric Biosciences Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications
Brief: Enveric Biosciences Receives Notice Of Allowance For New Class Of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
Brief: Enveric Biosciences Reports Positive Preclinical Results For Lead Drug Candidate EB-003
Brief: Enveric Biosciences Q1 Net Income USD -2.2 Million
Enveric Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary